It would be particularly useful to study PIK3CA inhibitors like Alpelisib (BYL719) which has been evaluated in only 2 PIK3CA mutated HNSCC cell lines39. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.